New antimicrobial and antithrombogenic medical device

[en] The present invention relates to a new medical device comprising polyhydroxyurethane, particularly a catheter or a prosthetic heart valve and a method of manufacturing thereof. The present invention also relates to the use of the medical device to load and release a bioactive molecule, particularly an antibacterial or anti-thrombotic molecule.

Research Center/Unit :

Complex and Entangled Systems from Atoms to Materials (CESAM) Research Unit
Center for Education and Research on Macromolecules (CERM)

Disciplines :

Materials science & engineering
Cardiovascular & respiratory systems
Biotechnology
Materials science & engineering
Chemistry

Inventor :

Pierrard, Anna ; University of Liège (ULiège), Complex and Entangled Systems from Atoms to Materials (CESAM) Research Unit, Center for Education and Research on Macromolecules (CERM), Belgium

Aqil, Abdelhafid ; Université de Liège - ULiège > GIGA > GIGA Cardiovascular Sciences - Cardiology

Detrembleur, Christophe ; University of Liège (ULiège), Complex and Entangled Systems from Atoms to Materials (CESAM) Research Unit, Center for Education and Research on Macromolecules (CERM), Belgium

Jérôme, Christine ; University of Liège (ULiège), Complex and Entangled Systems from Atoms to Materials (CESAM) Research Unit, Center for Education and Research on Macromolecules (CERM), Belgium

LANCELLOTTI, Patrizio ; Université de Liège - ULiège > GIGA > GIGA Cardiovascular Sciences

Oury, Cécile ; Université de Liège - ULiège > GIGA > GIGA Cardiovascular Sciences - Cardiology ; Université de Liège - ULiège > Département des sciences biomédicales et précliniques

Ferreira Melo, Sofia ; Université de Liège - ULiège > GIGA > GIGA Cardiovascular Sciences - Cardiology

Language :

English

Title (54) :

New antimicrobial and antithrombogenic medical device

Publication date (43-45) :

01 September 2022

Filing date (22) :

25 February 2022

Patent/publication number (10-11) :

WO2022180235

Patent status (13) :

Priority number (30) :

EP21159597A·2021-02-26

International classification (IPC) (51) :

C08G18/24; C08G18/48; C08G18/75; C08G71/04; C09D175/04

European classification (ECLA) (52) :

C08G18/246 (EP); C08G18/4845 (EP); C08G18/758 (EP); C08G71/04 (EP); C09D175/04 (EP)

Applicant (71) :

Université de Liège (ULiege), Centre Hospitalier Universitaire de Liège (CHU)

Publication organism (19) :

WIPO

Available on ORBi :

since 25 May 2022

Statistics

Number of views

133 (34 by ULiège)

Number of downloads

44 (15 by ULiège)

More statistics